Clinical trial
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in…
NCT00004157 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004157 |
|---|---|
| Title | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors |
| Official title | Combination of Interleukin 11 (Neumega) With G-CSF to Mobilize Autologous Peripheral Blood Stem Cells (PBSC) |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Gestational Trophoblastic Tumor, Kidney Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor |
| Intervention type | Biological |
| Interventions | filgrastim, recombinant interleukin-11 |
| Start date | Aug 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Feb 12, 2004 |
| Last update posted | Apr 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: